Drug prices are suppressed overseas, White House study finds

Wall Street Journal

13 February 2020 - Foreign governments accused of taking unfair advantage of U.S. company research.

Foreign governments are taking unfair advantage of American drug company research and U.S. consumers by artificially suppressing drug prices abroad, a new study from the White House said.

The findings suggest drug pricing could become another source of friction between the U.S. and trading partners, similar to China’s appropriation of U.S. intellectual property and European “digital taxes” on big American technology companies.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing